1nhaler raises £2.2m to take pop-up dry-powder inhaler to the clinic
Drug delivery device developer 1nhaler has raised £2.2m ($2.9m) to advance the development of its cardboard-based pop-up asthma inhaler through…
News
Roche lands FDA clearance for respiratory testing panel
Abbott’s Amulet 360 demonstrates strong one-year outcomes in AFib patients
HistoSonics gains Singapore approval for Edison histotripsy system
Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal
UK Biobank study initiated to assess early indicators of neurodegeneration
Dexcom lifts 2026 revenue outlook after positive Q3
Omron Healthcare begins production at first India plant
